Progyny, Inc.

NASDAQ:PGNY

Medical - Healthcare Information Services

Healthcare
$36.16 -0.19%

-$0.05 today

Market cap
$2.66B
Beta
1.04
P/E (TTM)
31.4
EPS (TTM)
$0.84
52W Low $16.10High $28.75

Volume 0.88M

Average 1.49M

PGNY Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

Progyny, Inc.NASDAQ: PGNY

Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026

Depreciation & amortization growth accelerates

Q2 FY2026 depreciation & amortization of $3.11M rose 157.8% year over year, ahead of the +79.8% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 109.4% from the prior quarter. Over 3 fiscal years it compounded at +45.7% a year.

Context

  • Depreciation & amortization amounted to 0.4% of revenue in FY2025, up 0.1 pp from a year earlier.
  • Depreciation & amortization increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +157.8% holds above the trailing-twelve-month pace of +79.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$3.11M+109.4% QoQ
Last fiscal yearDec 2025
$4.95M+55.8% YoY
LTMJun 2026
$7.22M+79.8% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+157.8%——
1 year+55.8%——
3-year CAGR+45.7%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
4.95M USD
Year-over-year change
+55.8%
4-year CAGR
+39.6%

Depreciation & Amortization vs competitors

How PGNY compares with its peers on the latest reported figures

  • PGNY's LTM Jun 2026 depreciation & amortization of $7.22M is the 2nd highest of the 3 companies compared; the peer median is $81.65M.
  • Its year-over-year change of +79.8% is the highest of 3, against a peer median of +6.7%.
  • Depreciation & amortization amounts to 0.6% of revenue for PGNY, versus a peer median of 6.8%.
PGNY Competitors Peer median
Depreciation & Amortization for PGNY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HQYHealthEquity, Inc.LTM Jul 2026$157.63M +0.3%-1.4%11.6%
PGNYProgyny, Inc.LTM Jun 2026$7.22M +79.8%+45.7%0.6%
OMDAOmada HealthLTM Mar 2026$5.67M +13.1%+8.2%2.0%
Peer median (excluding PGNY) $81.65M+6.7%+3.4%6.8%

Competitors are the stored peer set for PGNY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue500.62M786.91M1.09B1.17B1.29B
Cost of Revenue388.49M619.59M849.8M913.86M984.18M
Gross Profit112.14M167.33M238.8M253.36M304.48M
Gross Margin22.4%21.3%21.9%21.7%23.6%
Research & Development00000
Selling, General & Admin79.8M143.98M176.62M185.91M219.21M
Operating Expenses79.8M143.98M176.62M185.91M219.21M
Depreciation & Amortization1.3M1.6M2.28M3.18M4.95M
EBITDA33.74M26.04M72.97M86.38M100.38M
EBITDA Margin6.7%3.3%6.7%7.4%7.8%
Operating Income32.34M23.34M62.18M67.46M85.28M
Operating Margin6.5%3.0%5.7%5.8%6.6%
Interest Income461K814K8.51M15.75M10.16M
Interest Expense00000
Other Income / Expenses95K1.1M8.51M15.75M10.16M
Income Before Tax32.44M24.44M70.69M83.2M95.43M
Pre-Tax Margin6.5%3.1%6.5%7.1%7.4%
Income Tax Expense(33.33M)(5.92M)8.65M28.87M36.91M
Net Income65.77M30.36M62.04M54.34M58.52M
Net Margin13.1%3.9%5.7%4.7%4.5%
EPS (Basic)0.740.330.650.590.68
EPS (Diluted)0.660.300.620.570.65
Weighted Avg Shares89.11M92.2M95.02M91.48M85.23M
Weighted Avg Shares (Diluted)100.36M99.96M100.67M95.45M89.46M

Progyny, Inc.

NASDAQ:PGNY

Intrinsic Alpha fair value

Locked

Current Price

$36.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.